Skip to main content
. 2020 Oct 2;11:583171. doi: 10.3389/fphar.2020.583171

Table 4.

The role of Tripterygium ingredients for DCs.

Component Models Molecular mechanism Effects Animal disease phenotype Ref.
Duantengyimu decoction GM-CSF and IL-4 stimulate PBMCs isolated from patients with RA NA Decrease the expression of CCR5 and CCR7, decrease the secretion of CXCL9 and CXCL10, and inhibit the migration of DC NA (Sun, 2017)
Tripterygium Wilfordii Saponins GM-CSF, TNF-α, and IL-4 stimulate PBMCs NA Inhibit the expressions HLA-DR and CD80 on the membrane. Decrease the synthesis of IL-12 p40 subunit NA (Wang et al., 2001)
Tripterygium glycosides DCs isolated from rats NA Reduce the expression of MHC-II, CD80, CD86, and CD40 on the membrane of DC NA (Chen et al., 2006)

TP, Triptolide; Caspase, Aspartic acid protease containing cysteine; CCR, Chemokine receptor; CXCL, C-X-C motif chemokine ligand; MAP, Mitogen activated protein; MHC, Major histocompatibility complex.